Mentari Therapeutics, Inc. MTRI
15.61 USD +3.21 (+25.88%)
At closeNov 11, 2026, 6:12 PM EST
15.60 -0.01 -0.06%
After hours · Nov 11, 6:12 PM ET
12.50 Day range 16.50
5.75 52-week range 23.30
- YTD
- +47.25%
- 1 year
- -10.29%
MTRI revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2026 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2026 | 2026-06-30 | 0 | 0 | Not meaningful |
| FY 2025 | 2025-06-30 | 0 | -4,597,730 | -100.00% |
| FY 2024 | 2024-06-30 | 4,597,730 | 462,169 | 11.18% |
| FY 2023 | 2023-06-30 | 4,135,561 | 3,046,126 | 279.61% |
| FY 2022 | 2022-06-30 | 1,089,435 | 1,089,435 | Not meaningful |
| FY 2021 | 2021-06-30 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-06-30 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-06-30 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-11T07:00:37.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.